---
title: "Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Ath... — FDA record D-0029-2025 | Is It on Recall"
description: "Superpotent Drug: Stability failure for assay at 6 months test time-point."
url: https://isitonrecall.com/recall/fda-drug-d-0029-2025-chlorpheniramine-maleate-4-mg-tablets-24-count-bottle-manufactured-for-athlete-s-needs-novi-mi-48377/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-... — FDA record D-0029-2025

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 21, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24
- **Reason**: Superpotent Drug: Stability failure for assay at 6 months test time-point.
- **Classification**: Class II
- **Recalling firm**: BLI International, Inc.
- **Quantity**: 4,901 cases/24 count each case
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0029-2025

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0029-2025%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # 24A27724, Exp 01/31/2027 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Product was shipped to two private label customers ( OH & MO) as a final packaged product.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Missouri](https://isitonrecall.com/state/missouri/)
- [Ohio](https://isitonrecall.com/state/ohio/)

## Dates in the source

- **Report date**: Nov 6, 2024
- **Recall initiation date**: Oct 21, 2024
- **Center classification date**: Oct 30, 2024
- **Termination date**: Dec 5, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0029-2025%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [BLI International, Inc. records](https://isitonrecall.com/brand/bli-international-inc/)